Popular Articles

Kansas Becomes Central Battleground In Abortion-Rights Debate
Kansas has become "perhaps the fiercest battleground" in the abortion-rights debate with mass protests, prosecutions, lawsuits and the recent murder of abortion provider George Tiller, the AP/Washington Post reports. Kansas State University political scientist Joe Aistrup said, "There"s a very prominent vein in Kansas politics that tends toward moral righteousness." He said that this contributes to that unending debate and has produced extremists on both sides of the issue in the state.Peter Brownlie, CEO of Planned Parenthood of Kansas and Mid-Missouri, said that the majority of those who maintain the intense debate on abortion rights are political leaders. "There is a very clear and growing gap between the general public and the political leaders who are committed to this being such a constant and volatile issue," he said. Brownlie added that on issues relating to abortion, sex education and family planning, "Kansans" views are not markedly different from most Americans, but there are political forces at work, some of them well beyond the state borders."The Post reports that Kansas is different than most states where either supporters or foes of abortion rights dominate. According to the AP/Post, Kansas often sways between having key lawmakers who support abortion rights and those who oppose them. For example, a Republican-dominated Legislature over the past six years passed several bills to restrict abortion access, but much of the legislation was vetoed by former Gov. Kathleen Sebelius (D). The result has triggered frustration in groups opposing abortion rights, and they continue to feed widespread opposition to abortion in the state, the AP/Post reports.According to Burdett Loomis, a University of Kansas political science professor, there even is a split among Kansas Republicans in regard to abortion rights, as some Republicans in the state are evangelical Christians who oppose abortion rights, while others are moderates who support such rights. He said the split "might pop out in gun laws, home schooling, evolution, but it starts and stops with abortion" (Crary/Hanna, AP/Washington Post, 6/3).Wall Street Journal Examines Abortions Later in PregnancyIn related news, the Wall Street Journal on Thursday examined how Tiller"s clinic in Kansas became a battleground in the abortion-rights debate particularly because some of his patients were in the second and third trimesters of pregnancy. According to the Journal, even though the subject of abortion later in pregnancy is the of "a deep cultural divide," both sides agree that it is "anguishing." Fewer than 1% of all abortions in the U.S. are performed in the second or third trimesters, and most states prohibit abortions late in pregnancy but include exceptions for the woman"s life and health.The Journal reports that abortion procedures performed later in pregnancy often carry increased health risks, are more expensive and are emotional. The Guttmacher Institute reports that 8.9 maternal deaths occur during every 100,000 abortions performed later in pregnancy, compared with 7.1 deaths per 100,000 births. The article also profiled women who chose to undergo abortions later in pregnancy at Tiller"s clinic, as well as arguments from abortion-rights opponents (Simon, Wall Street Journal, 6/4).
generic viagra online
EU Food Facility Grant To Boost Farmers' Productivity In Asia And Africa
Small-scale farmers in Bangladesh, Pakistan and Sierra Leone are soon to receive a productivity boost, thanks to innovative projects of the UN World Food Programme (WFP) funded with a 39-million euro donation from the European Union (EU).
News of the day
Alexion's Soliris(R) Receives 2009 Prix Galien France For Most Innovative Drug For Rare Disease
Alexion Pharma France and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today received the 2009 Prix Galien France for Soliris® (eculizumab) in the category of medicines for rare diseases. The award recognizes the scientific innovation represented by the complement-inhibition technology of Soliris, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare, debilitating and life-threatening blood disorder.
Diagnostics

Recent Releases On Global Health

Lancet Commends U.K. All-Parliamentary Group on AIDS Call For HIV Drug Patent Pool A Lancet editorial examines recent recommendations by the U.K. All-Parliamentary Group on AIDS for pharmaceutical companies to implement an HIV drug patent pool - an appeal, "Drug companies have dismissed" in the past. The authors conclude, "Although the voice of the All-Parliamentary Group is a welcome addition to the fight for improved access to essential medicines, unless there is political clout behind the rhetoric, drug companies will continue to resist potential solutions, such as patent pools" (7/25). Eroded Social Systems Unable To Feed World"s Poor A Lancet perspective piece examines why social systems around the world have become "eroded" and are unable to feed "impoverished people." According to the article, "As a result of the present economic and development crisis, the World Bank should be challenged to radically change its lending policies and engage in local development for freedom." It lists four recommendations to achieve this (Heikins, 7/25). Tailoring HIV Interventions To Men"s Needs "Emerging evidence suggests that we are far more successful at providing combination antiretroviral therapy (cART) to women than to men," according to a Lancet comment. The authors write that "men"s health-seeking behaviour are poorly understood in the AIDS epidemic, and encouraging men to get tested and into treatment is a major challenge, but one that is poorly recognised." They conclude that "far from being seen as a challenging group requiring specific interventions, reflections on men and HIV/AIDS are usually limited to their culpability as drivers of the epidemic" (Mills et al., 7/25). Report Tracks Global Development Assistance A Kaiser Family Foundation report released tracks the most recently available data on official development assistance from the U.S., European Community and other donor nations to low- and middle-income countries. The data reflects decisions made prior to the current global economic crises, which could threaten donor support for sustaining and building on global health efforts. However, the recent U.S. announcement of a new multi-year global health initiative and the G8"s reiteration of its health-related commitments suggest global health remains a key concern for donor nations (7/23). JAMA Explores Ancillary Care In Developing Countries JAMA Grand Rounds explores what a researchers" responsibility is to providing clinical care for conditions discovered during clinical trials in developing countries. The piece "argues that investigators can have a responsibility to provide care for a wide range of health needs, including at times care for conditions not connected to the research question or study procedures" (Dickert et al., 7/22). An accompanying commentary says, "More discussion of ancillary care as an important emerging issue for global reflection in research ethics is needed" and appeals for "[p]ublic health researchers and sponsors [to] reflect on ancillary care issues characteristic of group-focused public health research in low-re settings" (Hyder et al., 7/22). PLoS Medicine Examines Efforts To Strengthen Regulatory Agencies In Developing Countries A PLoS Medicine Policy Forum examines how as "preventative vaccines for global diseases are becoming a reality," regulatory agencies such as the FDA, Health Canada and the European Union"s European Medicines Agency (EMEA) are working to help strengthen developing country regulatory authorities that often "lack the capacity to review applications for new vaccines, resulting in lengthy delays in obtaining permission to conduct clinical trials" (Brennan, 7/21). PLoS Medicine Examines Policies To Improve AMFm Implementation Another PLoS Medicine Policy Forum examines the Affordable Medicines Facility-malaria (AMFm) program, "that aims to address inadequate access to [artemisinin-based combination therapies (ACTs)] for treating P. falciparum malaria by subsidizing producer prices." With the facility expected to begin operations in late 2009, the authors suggest policies AMFm can adopt to improve patient care and measures that could improve AMFm implementation, among other issues (Moon et al., 7/21). Study Examines Health Worker Attrition Rates In Kenya A Human Res For Health study examines health worker attrition rates across Kenya. The study recommends additional investigation and finds that "appropriate policies to retain staff in the public health sector may need to be tailored for different cadres and level of health facility" (Chankova, et al., 7/21). Developing Scientific Research Capacity In Low-Income Countries A PLoS Biology article explores how to develop scientific research capacity in low-income countries. "Research is a major driver of social and technological innovation that can lead to health and equity improvements through a knowledge-to-action process," the authors write. The article concludes: "Global health goals will be achievable when the necessary tools and knowledge are in the hands of our colleagues in the South, along with adequate human and physical infrastructure for health care and health research, supported by a dynamic international community" (Coloma/Harris, 7/21). www.smartglobalhealth.org Launched By CSIS Commission The newly formed Commission on Smart Global Health Policy from the Center for Strategic and International Studies launched its Web site this week - www.smartglobalhealth.org. This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):